If you liked this article you might like

Teva, Actavis, Other Generic Drugmakers May Be on Acquisition Trail
Jim Cramer -- Deal Activity in Specialty Pharma Reaches a Frenzied Pace
Why Endo International Can Deliver Solid Rewards With Minimal Risk